C

CD-Venture

Europe, Baden-Wurttemberg, Germany, Heidelberg

Description

C.D. Ventures works collaboratively with clients to design sustainable change management solutions in Texas.

Investor Profile

CD-Venture has made 19 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (37%)
  • Series A (21%)
  • Series C (21%)
  • Seed (11%)
  • Series Unknown (5%)
  • Series D (5%)

Country Focus

  • United States (47%)
  • Germany (42%)
  • Canada (11%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Genetics
  • Health Diagnostics
  • Pharmaceutical
  • Information Technology
  • Mhealth
  • Personal Health
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CD-Venture frequently co-invest with?

BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Baird Capital
North America, Wisconsin, United States, Milwaukee
Co-Investments: 3
Aeris Capital
Europe, Zurich, Switzerland, Pfaffikon
Co-Investments: 4
TVM Capital Life Science
Europe, Bayern, Germany, Munich
Co-Investments: 3
NGN Capital
North America, New York, United States, New York
Co-Investments: 4
Partnership Fund for New York City
North America, New York, United States, New York
Co-Investments: 3
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 5
Arcus Ventures
North America, New York, United States, New York
Co-Investments: 4
Yabeo
Europe, Bayern, Germany, Grünwald
Co-Investments: 3
AC
Oceania, New South Wales, Australia, Sydney
Co-Investments: 3

Which angels does CD-Venture often collaborate with?

KK
Europe, Baden-Wurttemberg, Germany, Karlsruhe
Shared Deals: 1
LD
North America, Virginia, United States, Richmond
Shared Deals: 1
FW
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by CD-Venture?

leon nanodrugs

München, Bayern, Germany

leon-nanodrugs is a nanotechnology-based drug development company.

BiotechnologyHealth CareMedicalPharmaceutical
Series DAug 6, 2024
Wellth

Los Angeles, California, United States

Wellth motivates medication adherence using Behavioral Economics

Health CareInformation TechnologymHealthPersonal Health
Series BMar 30, 2023
Amount Raised: $20,000,000
Wellth

Los Angeles, California, United States

Wellth motivates medication adherence using Behavioral Economics

Health CareInformation TechnologymHealthPersonal Health
Series AMay 6, 2020
Amount Raised: $10,000,000
TriOptoTec

Regensburg, Bayern, Germany

TriOptoTec is a speciality disinfectant producer.

Health CarePharmaceutical
Series CApr 21, 2020
leon nanodrugs

München, Bayern, Germany

leon-nanodrugs is a nanotechnology-based drug development company.

BiotechnologyHealth CareMedicalPharmaceutical
Series BApr 16, 2020
Wellth

Los Angeles, California, United States

Wellth motivates medication adherence using Behavioral Economics

Health CareInformation TechnologymHealthPersonal Health
SeedSep 2, 2018
Amount Raised: $5,100,000
Exosome Diagnostics

New York, New York, United States

Exosome Diagnostics develops and commercializes blood-based cancer molecular diagnostics for patient stratification and disease monitoring.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series CJul 24, 2017
Amount Raised: $30,000,000
Exosome Diagnostics

New York, New York, United States

Exosome Diagnostics develops and commercializes blood-based cancer molecular diagnostics for patient stratification and disease monitoring.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series BJan 7, 2016
Amount Raised: $16,000,000
Exosome Diagnostics

New York, New York, United States

Exosome Diagnostics develops and commercializes blood-based cancer molecular diagnostics for patient stratification and disease monitoring.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series BSep 2, 2015
Amount Raised: $17,600,000
leon nanodrugs

München, Bayern, Germany

leon-nanodrugs is a nanotechnology-based drug development company.

BiotechnologyHealth CareMedicalPharmaceutical
Series AJul 27, 2015
Amount Raised: $20,513,571